European Price Cuts, Restructuring Charges, Hit France's Ipsen in 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
Ipsen's restructuring in France and the U.S, and European austerity measures, lead to a series of charges against 2011 profits, but drug sales increase 5% in the year.